Volume 11, Number 1, January 2005

Demand for Prophylaxis after Bioterrorism-Related Anthrax Cases, 2001

Edward A. Belongia,* Burney Kieke,* Ruth Lynfield,† Jeffrey P. Davis,‡ and Richard E. Besser§
*Marshfield Clinic Research Foundation, Marshfield, Wisconsin, USA; †Minnesota Department of Health, Minneapolis, Minnesota, USA; ‡Wisconsin Division of Public Health, Madison, Wisconsin, USA; and §Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Figure 2. A) Retail distribution of fluoroquinolone antimicrobial agents, January 1999 through December 2002. Volume was measured in kilograms. B) Actual and predicted retail distribution of fluoroquinolone antimicrobial agents as a percentage of total antibiotic volume distribution (excluding tetracyclines), January 1999 through December 2002. Vertical bars show 95% confidence intervals.

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page last reviewed December 6, 2004

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention